Skip to main content

Overview

A deal is one biopharma transaction: an acquisition, merger, asset purchase, licensing agreement, collaboration, option, joint venture or distribution agreement. Each deal keeps one stable deal_id as new filings and releases report on it, and carries its parties, its headline economics, its lifecycle from proposal to completion or termination, and the source documents behind every term. Questions this dataset answers:
  • What are the largest biopharma acquisitions by headline value?
  • Which deals has Eli Lilly done this year, and on what terms?
  • Which licensing deals were announced since January, and for which rights?
  • Where does a stated upfront or milestone figure come from?

Coverage

Many deals disclose no value. min_value_usd and sort=headline_value only consider deals with a stated USD headline value.

Key fields

GET /v1/deals/{deal_id} adds terms (headline value, upfront, equity, milestones, royalties, territories, rights), events[] with the source URL of each lifecycle step, and source_documents[].

Endpoints

Filters

All filters are optional and combine with AND. With no filters you get the most recent deal activity.

Largest deals

Example response (trimmed)

A company’s deals

Example response (trimmed)

Get one deal with terms and sources

Example response (trimmed)